CIN2+ | CIN3+ | |||||
---|---|---|---|---|---|---|
RR(95%CI) | P-value | RR(95%CI) | P-value | |||
Aged 20–29 | ||||||
Unvaccinated | 1.00 | Reference | 1.00 | Reference | ||
Vaccinated | 0.33 | (0.15, 0.73) | 0.006 | 0.09 | (0.00, 0.41) | 0.002 |
Age | 1.04 | (0.98, 1.10) | 0.233 | 1.06 | (0.00, 1.17) | 0.246 |
Aged 20–29 (no overlapping) | ||||||
Unvaccinated | 1.00 | Reference | 1.00 | Reference | ||
Vaccinated | 0.24 | (0.10, 0.60) | 0.003 | 0.09 | (0.00, 0.42) | 0.002 |
Age | 1.03 | (0.97, 1.09) | 0.360 | 1.06 | (0.96, 1.17) | 0.246 |
Aged 20–22 | ||||||
Unvaccinated | 1.00 | Reference | ||||
Vaccinated | 0.23 | (0.06, 0.81) | 0.023 | |||
Age | 0.95 | (0.51, 1.76) | 0.869 | |||
Aged 20–22(no overlapping) | ||||||
Unvaccinated | 1.00 | Reference | ||||
Vaccinated | 0.16 | (0.03, 0.72) | 0.017 | |||
Age | 0.89 | (0.47, 1.68) | 0.709 |